AstraZeneca profit climbs on cancer and heart drug demand


The pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on Tuesday.

You May Also Like

Wall Street bull warns of pause in rally but sees S&P 500 grinding higher in 2024

U.S. stocks are likely to start 2024 with a breather and to…

China’s reclusive young ‘rat people’ stay in bed all day and gnaw away at the country’s economic outlook

A growing youth trend of withdrawal and low-desire living is complicating Beijing’s…

Stocks and crypto could rally through year-end, but watch for this last wild card

Lower interest rates, declining inflation and higher corporate profits could power stocks’…

Lyft says two board members have resigned

Ride-hailing platform Lyft Inc. on Friday said that Mary Agnes Wilderotter and…